Identification of Novel 1- O-Substituted Aporphine Analogues as Potent 5-HT2C Receptor Agonists

ACS Chem Neurosci. 2020 Feb 19;11(4):549-559. doi: 10.1021/acschemneuro.9b00563. Epub 2020 Feb 4.

Abstract

The 5-HT2C receptor has emerged as a promising target in the treatment of a variety of central nervous system disorders. We have first identified aporphines as a new class of 5-HT2C receptor agonists. Structure-activity relationship results indicate that the aporphine core may be required for 5-HT2C receptor activity, and substitutions at its C1 position are important for 5-HT2C receptor activity. Our efforts to optimize our hit 15781 lead to the identification of the highly potent and selective 5-HT2C agonist 18b (MQ02-439) with an EC50 value of 104 nM and weak antagonism at the 5-HT2A and 5-HT2B receptors. The findings may serve as good starting points for the development of more potent and selective 5-HT2C agonists as valuable pharmacological tools or potential drug candidates.

Keywords: 5-HT2A receptor; 5-HT2B receptor; 5-HT2C receptor; Serotonin; agonist; aporphine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aporphines / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Radioligand Assay
  • Receptor, Serotonin, 5-HT2A / drug effects
  • Receptor, Serotonin, 5-HT2C / drug effects*
  • Receptor, Serotonin, 5-HT2C / metabolism
  • Serotonin 5-HT2 Receptor Agonists / pharmacology*
  • Structure-Activity Relationship

Substances

  • Aporphines
  • Receptor, Serotonin, 5-HT2A
  • Receptor, Serotonin, 5-HT2C
  • Serotonin 5-HT2 Receptor Agonists